605 related articles for article (PubMed ID: 23526674)
1. Acute kidney injury during vancomycin therapy in critically ill children.
Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J
Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
[TBL] [Abstract][Full Text] [Related]
4. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Holsen MR; Meaney CJ; Hassinger AB; Fusco NM
Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
Zappitelli M; Moffett BS; Hyder A; Goldstein SL
Nephrol Dial Transplant; 2011 Jan; 26(1):144-50. PubMed ID: 20591815
[TBL] [Abstract][Full Text] [Related]
6. Drug use density in critically ill children and newborns: analysis of various methodologies.
Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
[TBL] [Abstract][Full Text] [Related]
7. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
[TBL] [Abstract][Full Text] [Related]
8. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
9. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A
J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
Cies JJ; Shankar V
Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
[TBL] [Abstract][Full Text] [Related]
11. Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Slater MB; Gruneir A; Rochon PA; Howard AW; Koren G; Parshuram CS
Paediatr Drugs; 2017 Feb; 19(1):59-67. PubMed ID: 27943125
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with acute kidney injury in children receiving vancomycin.
Sinclair EA; Yenokyan G; McMunn A; Fadrowski JJ; Milstone AM; Lee CK
Ann Pharmacother; 2014 Dec; 48(12):1555-62. PubMed ID: 25186624
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of acute kidney injury in Canadian critical care units: a prospective cohort study.
Odutayo A; Adhikari NK; Barton J; Burns KE; Friedrich JO; Klein D; Lapinsky S; Litwin S; Meret A; Moineddin R; Richardson B; Richardson R; Zaltzman A; Hladunewich M; Wald R
Can J Anaesth; 2012 Oct; 59(10):934-42. PubMed ID: 22843289
[TBL] [Abstract][Full Text] [Related]
15. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit.
Schneider J; Khemani R; Grushkin C; Bart R
Crit Care Med; 2010 Mar; 38(3):933-9. PubMed ID: 20124891
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use.
Mendes CA; Cordeiro JA; Burdmann EA
Ann Pharmacother; 2009 Dec; 43(12):1948-55. PubMed ID: 19887593
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
18. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
[TBL] [Abstract][Full Text] [Related]
20. Administrative data misclassifies and fails to identify nephrotoxin-associated acute kidney injury in hospitalized children.
Schaffzin JK; Dodd CN; Nguyen H; Schondelmeyer A; Campanella S; Goldstein SL
Hosp Pediatr; 2014 May; 4(3):159-66. PubMed ID: 24785560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
